Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DLB | Class A Common Stock | Options Exercise | $1.87M | +50K | +51.95% | $37.35 | 146K | Feb 6, 2023 | Direct | F1 |
transaction | DLB | Class A Common Stock | Sale | -$3.53M | -41.7K | -28.54% | $84.48 | 105K | Feb 6, 2023 | Direct | F1, F2 |
transaction | DLB | Class A Common Stock | Sale | -$704K | -8.26K | -7.91% | $85.24 | 96.2K | Feb 6, 2023 | Direct | F1, F3 |
transaction | DLB | Class A Common Stock | Options Exercise | $566K | +15.2K | +15.74% | $37.35 | 111K | Feb 7, 2023 | Direct | F1 |
transaction | DLB | Class A Common Stock | Options Exercise | $994K | +21.9K | +19.61% | $45.50 | 133K | Feb 7, 2023 | Direct | F1 |
transaction | DLB | Class A Common Stock | Sale | -$2.62M | -31.2K | -23.42% | $83.86 | 102K | Feb 7, 2023 | Direct | F1, F4 |
transaction | DLB | Class A Common Stock | Sale | -$489K | -5.8K | -5.68% | $84.37 | 96.2K | Feb 7, 2023 | Direct | F1, F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DLB | Employee Stock Option (right to buy) | Options Exercise | $0 | -50K | -76.74% | $0.00 | 15.2K | Feb 6, 2023 | Class A Common Stock | 50K | $37.35 | Direct | F6 |
transaction | DLB | Employee Stock Option (right to buy) | Options Exercise | $0 | -15.2K | -100% | $0.00* | 0 | Feb 7, 2023 | Class A Common Stock | 15.2K | $37.35 | Direct | F6 |
transaction | DLB | Employee Stock Option (right to buy) | Options Exercise | $0 | -21.9K | -100% | $0.00* | 0 | Feb 7, 2023 | Class A Common Stock | 21.9K | $45.50 | Direct | F7 |
Id | Content |
---|---|
F1 | Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest. |
F2 | This transaction was executed in multiple trades at prices ranging from $84.03 to $85.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
F3 | The shares were sold in multiple transactions at prices ranging from $85.04 to $85.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
F4 | This transaction was executed in multiple trades at prices ranging from $83.26 to $84.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
F5 | This transaction was executed in multiple trades at prices ranging from $84.26 to $84.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
F6 | This option was granted for a total of 65,153 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. |
F7 | This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 21,850 shares. |
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.